Two novel (M233T and ρ278T) presenilin-1 mutations in early-onset Alzheimerʼs disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype-Reference-Cited by-同舟云学术

Two novel (M233T and ρ278T) presenilin-1 mutations in early-onset Alzheimerʼs disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype

Published:1997-04 Issue:6 Volume:8 Page:1537-1542
ISSN:0959-4965
Container-title:NeuroReport
language:en
Short-container-title:NeuroReport

Author:

Kwok John B. J.,Taddei Kevin,Hallupp Marianne,Fisher Christopher,Brooks William S.,Broe Gerald A.,Hardy John,Fulham Michael J.,Nicholson Garth A.,Stell Rick,St. George Hyslop Peter H.,Fraser Paul E.,Kakulas Byron,Clarnette Roger,Relkin Norman,Gandy Samuel E.,Schofield Peter R.,Martins Ralph N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Neuroscience

Reference4 articles.

1. Evidence that A?42 is the real culprit in alzheimer's disease

2. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

3. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

4. Presenilins and Alzheimer disease

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research;International Journal of Molecular Sciences;2024-02-28

2. Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene;International Journal of Molecular Sciences;2022-09-19

3. Recent Advances in the Modeling of Alzheimer’s Disease;Frontiers in Neuroscience;2022-03-31

4. Clinical and Molecular Findings in a Turkish Family Who Had a (c.869- 1G>A) Splicing Variant in PSEN1 Gene with A Rare Condition: The Variant Alzheimer's Disease with Spastic Paraparesis;Current Alzheimer Research;2022-03

5. Spastic paraplegia preceding PSEN1 ‐related familial Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2021-01